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Abstract
E-mental health is an emerging area of research that has the potential to overcome some of the current barriers to progress in
working with people at clinical high risk for psychosis (CHR-P). This article provides an overview of how e-mental health could
be used in the detection, prediction, and treatment in the CHR-P population. Specifically, we evaluate e-detection, e-prediction,
and e-therapeutics for this clinical population. E-mental health holds great promise to improve current management of CHR-P
individuals.
(JMIR Ment Health 2019;6(10):e14581)  doi: 10.2196/14581
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Introduction
The identification of people at clinical high risk for psychosis
(CHR-P) [1] offers a unique opportunity to alter the illness
course of psychotic disorders [2]. These individuals often have
several risk factors for psychosis [3] and typically present with
attenuated psychotic symptoms in the context of a recent decline
in functioning [4]. They display symptoms and functional
impairments that are qualitatively similar to those observed in
established mental disorders [5]. The risk of transition to
psychosis within 2 years in these individuals is approximately
20% [6]. This risk is not the same across the different CHR-P
subgroups. In particular, individuals meeting criteria for
short-lived psychotic episode show a distinctive and very high
risk of developing persistent psychotic disorders that cumulates
to about 50% at 2 years [7]. CHR-P individuals presenting with
a short-lived psychotic episode that is spontaneously remitting
but characterized by disorganized behavior have an even higher
risk of developing a persistent psychotic disorder, cumulating
at 89% at 5 years [8]. These individuals also have unmet clinical
needs not typically addressed by the current configuration of
mental health services [9,10]. Overall, the risk for the
development of psychosis from a CHR-P stage has declined
from 29% [11] to 20% [6] in recent years, although not across
all sites [12]. This variable transition risk is due to different
sampling strategies being adopted to recruit these individuals
[13]. Emerging evidence indicates that the method of recruitment
prior to a CHR-P assessment is fundamental in enriching their
actual level of risk for psychosis [13].
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Although the CHR-P paradigm has been adopted in various
countries worldwide [14-17], a number of challenges have
arisen, hindering its penetrance into mainstream clinical practice.
The real-world success of the CHR-P paradigm rests on three
core components: an efficient detection of at risk cases, accurate
prediction of their outcomes, and effective preventative
treatments to alter the course of these outcomes Figure 1.
There are currently barriers to the implementation of each
component. First, well-established CHR-P services [17] detect
as low as 5% of first episode psychosis (FEP) patients before
illness onset [18]. Even within national youth mental health
services, the proportion of FEP cases detected at their CHR-P
stage is only 12% [19]. Second, although the prognostic
performance of the current CHR-P psychometric tools is
excellent [20], it is highly dependent on the way CHR-P
individuals are recruited [21]. Furthermore, prognostic outcomes
in this population are mostly based on group-level predictions,
and it is not yet possible to forecast the onset of psychosis at
the individual-subject level [22]. This is a substantial limitation
given that the CHR-P group is highly heterogenous and includes
different subpopulations with differing outcomes [7]. Third, no
specific preventive treatment appears to be more effective than
others in preventing onset of psychosis [23], treating attenuated
positive symptoms [24,25], treating attenuated negative
symptoms [26], treating depressive symptoms [27], reducing
distress [28], or improving social functioning [29]. Again, the
lack of evidence may partially reflect the fact that
one-size-fits-all approaches for this population do not work and
individualized treatments should be offered instead.
E-Mental health is a new approach that may be uniquely suited
to overcome some of these barriers. Individuals at CHR-P have
a young age range (most criteria are set at 14 to 35 years) and
as such tend to be highly engaged with the digital world [30].
Although previous reviews have highlighted the emerging
potential for e-mental health in psychosis [31-34], there is
currently no overview focusing on the potential and prospects
specifically in CHR-P. In this article, we provide an overview
how e-mental health can be applied to the detection, prediction,
and treatment of CHR-P. Studies included in this overview are
summarized in Table 1. Although this is not a systematic review
and there is no assumption that the literature surveyed is
comprehensive, we provide our search strategy and inclusion
criteria in Multimedia Appendix 1.
Figure 1. Core clinical and research components for effective prevention of psychosis, from Fusar-Poli et al [35].
E-Detection
Detecting individuals at risk prior to the onset of psychosis has
been a key research priority over the past two decades since the
Personal Assessment and Crisis Evaluation study first developed
the concept of the CHR-P [16]. Typical inclusion in the CHR-P
group is based on attenuated psychotic symptoms, brief episodes
of psychosis, or functional deterioration in those with genetic
vulnerability for psychosis [35,36]. A distinct approach to the
identification of CHR-P individuals is the basic symptom
concept proposed by Huber and colleagues [37]. Basic
symptoms involve self-experienced perceptual and cognitive
anomalies that are thought to represent the earliest manifestation
of psychosis risk [38]. More recent studies have shown that the
combined presence of both basic symptom and CHR-P criteria
increases the predictive power significantly [39]. However, it
should also be noted that CHR-P participants who do not make
the transition to psychosis are characterized by extensive
psychiatric comorbidity and reduced occupational and social
functioning [40]. Accordingly, these two domains are also
potentially important for targets for e-mental health applications,
in terms of both prediction and preventive treatments.
Recruitment strategies have a significant impact on subsequent
transition rates of CHR-P cohorts, with self-referrals, assertive
community outreach, and population screening associated with
lower rates of transition to psychosis [41]. Despite the expansion
of CHR-P services, only a small proportion of FEP patients are
detected [42]. It is thus a key priority for CHR-P to improve
detection of individuals prior to the FEP while not diluting the
sample’s baseline risk of psychosis. As the majority of FEP
patients actively seek information regarding mental health issues
online as their symptoms first develop [43], early identification
of CHR-P individuals may be possible through digital detection
strategies. These could include online screening as well as use
of social media information. Recent evidence, for example,
suggests that references to sadness, loneliness, hostility,
rumination, and increased self-reference on Facebook predict
later onset of depression [44]. A similar approach may be useful
in CHR-P as the development of psychosis is characterized by
linguistic anomalies that can be detect by automated speech
analysis [45,46].
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Online screening has the potential to reach a greater number of
individuals compared with traditional routes of referral to
CHR-P services. McDonald et al [47] used a website for
detection of CHR-P in the community. Potential participants
were invited via email, flyers, and posters to a website [48] and
then asked to complete the 16-item version of the prodromal
questionnaire (PQ-16) and 9-item questionnaire of perceptual
and cognitive aberrations (PCA) for basic symptoms. This
allowed screening of a large number of individuals, 52.3%
(1202/2296) of whom met PQ-16 cutoff criteria and 73.6%
(1691/2296) of whom met PCA cutoff criteria. Of those meeting
screening cutoff criteria who then attended a clinic interview,
31.2% (101/324) met clinical CHR-P criteria. Importantly, a
subset of 8 individuals (2.5%) also met criteria for FEP.
Receiver operating characteristic curve analysis revealed good
to moderate sensitivity and specificity for predicting CHR-P
status based on the online results [47]. A machine-learning
approach that selected all 25 items from both the PQ-16 and
the PCA in addition to demographic variables lead to an
improved specificity of 57% while only marginally affecting
sensitivity (81%), compared with the original online screening
tool.
This study suggests that online screening of community samples
for emerging psychosis is possible, potentially identifying a
large number of people meeting CHR-P criteria. However, it is
currently unclear how many of these participants meeting
CHR-P criteria will actually develop psychosis. Accordingly,
2-year transition rates are needed to validate whether the sample
detected are truly at risk of developing a psychotic disorder or
whether they are false positives. A similar approach to
McDonald et al [47] has been implemented using the 32-item
self-screen prodrome questionnaire [49], although, again,
long-term transition rates are not known. Furthermore, the
validity of self-screening questionnaires, particularly when
conducted in nonclinical populations, has been questioned [50]
due to poor prognostic performance in predicting subsequent
psychosis.
More targeted screening of populations accessing secondary
mental health services that use electronic health records is also
possible through online screening. Our group developed a
psychosis risk calculator for patients already accessing
secondary mental health services [18]. This tool uses routine
clinical data including International Classification of Diseases,
Tenth Revision (ICD-10), spectra diagnoses to predict future
risk of developing a psychotic disorder and has been externally
validated twice in different National Health Service (NHS)
Trusts [51] showing an acceptable prognostic performance
(Harrell C of 0.73). Patients who have accessed secondary
mental health services have a 5-fold increased risk compared
with the general population [18], suggesting this may be an
efficient way of detecting new cases of psychosis while not
diluting the level of risk in the sample. As it uses routine clinical
data, the calculator could be used to automatically screen
electronic health records for those at increased risk of future
psychosis. However, it does rely on the assessment of health
professionals to provide ICD-10 diagnoses, and therefore it
cannot be used universally for self-screening. The calculator is
one of the few eHealth tools in the CHR-P population that is
being implemented into clinical routine practice [52].
The North American Prodrome Longitudinal Study has produced
an online risk calculator for individuals meeting CHR-P criteria
[53]. It showed an overall accuracy of 72% in predicting
psychosis when validated in an independent external data set
[54]. However, it requires input in the form of a structured
interview to confirm CHR-P status and neuropsychological
testing, limiting its applicability to wider clinical populations.
E-Mental health offers the opportunity for efficient, scalable
screening of those at risk of psychosis across populations that
are currently not reached by conventional recruitment,
potentially allowing better detection of individuals prior to their
FEP. Preliminary evidence suggests that it is indeed feasible.
The next step is determining whether these tools can be
implemented in practice to identify individuals at increased risk
of psychosis while not diluting the overall risk of the sample
with false positives.
E-Prognosis
The risk of transition to psychosis from CHR-P is maximal
within the first 2 years [55]. This period is therefore a crucial
time for predicting onset of psychosis. Traditionally, this has
been achieved through regular clinical monitoring from CHR-P
services to assess for transition to psychosis, but advances in
mobile phone technology offer the opportunity for a far greater
temporal resolution in monitoring changes in mental state that
may occur on a daily or even momentary basis.
The experience sampling method (ESM) uses mobile phones
to measure self-rated changes in mental state on a daily basis
[56]. It has excellent ecological validity and allows close
monitoring of mental state, particularly in regard to predictors
of transition to psychosis. ESM techniques in CHR-P were
initially rudimentary, requiring participants to fill out responses
in a paper diary when prompted by a wristwatch alarm [57,58].
Palmier et al [59] demonstrated that it is feasible to monitor
symptoms through a mobile phone app in a small sample (n=12)
of CHR-P individuals, paving the way for further cross-sectional
ESM studies. Klippel et al [60] showed in 46 CHR-P individuals
that momentary stress increased psychotic experiences via
affective disturbance using the PsyMate app. Reininghaus et al
[61] used ESM to link threat perception to psychotic experiences
in 44 CHR-P individuals and in another study [62] to show an
association with sensitivity to outsider status and aberrantly
salient experiences with psychotic experiences. Van der Steen
et al [63] used ESM to demonstrate an association between
affective and psychotic experiences in response to stress in
CHR-P individuals, showing an association between stress and
psychotic experiences. ESM has shown potential utility in
monitoring fine-grained changes in psychopathology during the
development of psychosis; however, longitudinal studies are
needed to determine its significance for predicting the onset of
psychosis. To date, one longitudinal study has been registered:
Booij et al [64] plan to predict outcome in various stages of
psychosis using mobile phone diary measures of symptoms,
stress, emotions, and functioning.
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Digital phenotyping, also known as personal sensing, is a novel
investigational technique whereby passive measures of mobile
phone activity are recorded in real-time [65], which has been
postulated to provide a digital phenotype of psychiatric disorders
[66]. These measures may include the participant’s interaction
with their phone (eg, call logs, number of messages, keyboard
use) as well as measures of their activity and movement (eg,
through accelerometers or Global Positioning System tracking).
Passive data provide a continuous readout every day and require
no active role by the participant, thus providing significant
advantages over traditional, episodic cross-sectional data.
Passive data are also potentially more ecologically valid than
symptom ratings elicited by standard questionnaires or
interviews, and there is reduced risk of subject attrition.
However, the use of passive mobile phone measures warrants
some important ethical considerations [65]. As with any
investigation, informed consent, data security, and
anonymization are crucial. Additionally, in those with psychotic
disorders, care must be taken not to exacerbate paranoia when
using participants’ personal devices. Passive measures therefore
may be particularly suited to CHR-P individuals, who retain
insight, particularly for the prediction of psychosis onset. Unlike
ESM, they do not require continual user input and may therefore
be less burdensome to participants. A pilot study suggests digital
phenotyping could predict relapse in schizophrenia based on
anomalies in patient behavior [67]; further studies in CHR-P
populations are underway, for example, using the MindStrong
app [68].
ESM and digital phenotypes have complementary strengths.
ESM provides explicit information about a patient’s state of
mind and as such is key to understanding their motivations and
behaviors, whereas digital phenotyping has the important
advantage of placing minimal burden on the patient apart from
keeping their mobile phone charged and as such is ideal for
clinical translation. Initial studies suggest that it might be
possible to use passive data generated via digital phenotyping
as a proxy for active data collected via ESM [69]; in the context
of CHR-P, this could enable the background monitoring of risk
of transition to psychosis with minimal interference on the
day-to-day life of patients.
In addition to informing diagnosis, prognosis, and treatment,
e-tools could be used to gain greater understanding of the
mechanisms that underlie transition to psychosis. For example,
our research team is currently using the Urban Mind app [70]
to investigate the impact of the surrounding social and physical
environment on risk of transition to psychosis in individuals at
CHR-P (see Figure 2 for user interface).
JMIR Ment Health 2019 | vol. 6 | iss. 10 | e14581 | p. 4https://mental.jmir.org/2019/10/e14581
(page number not for citation purposes)
Reilly et alJMIR MENTAL HEALTH
XSL•FO
RenderX
Figure 2. Urban Mind app user interfaces.
These studies suggest that e-mental health has potential value
in identifying risk factors for subsequent transition to psychosis
and predicting the onset of psychosis. In addition, these
approaches may also be applied toward prognosis for outcomes
other than transition to psychosis, such as functional outcomes
and development of nonpsychotic disorders. ESM and digital
phenotyping are two appealing methodologies with great
promise and are ideally suited to longitudinal designs to examine
the development of clinical trajectories in CHR-P populations.
E-Treatment
One criticism of CHR construct is that there is no treatment
conclusively shown to prevent the onset of psychosis [71].
However, there are several promising therapeutic strategies
currently under investigation that could significantly reduce
psychosis risk and address important additional areas of
impairment—in particular, cognitive deficits and social and
occupational functioning.
Since individuals at CHR-P do not have a mental disorder as
such, any treatment has to be well tolerated and acceptable.
Moreover, by definition these individuals retain a degree of
insight into their symptoms [72], offering a significant
therapeutic window of opportunity prior to the onset of
psychosis. Guidelines currently suggest psychological therapy
and recommend not treating with antipsychotic medication [73].
As various psychological therapies can be delivered online,
e-mental health has the potential to enhance access to treatments
and reduce costs. A systematic review and meta-analysis
suggested that guided online cognitive behavioral therapy (CBT)
for various psychiatric disorders had equivalent effect sizes
compared with face-to-face interventions [74], highlighting the
potential utility of administering CBT through digital modalities.
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Other psychological interventions such as mindfulness, which
has shown some efficacy for psychosis [75], may also be
effective when provided online [76]. Alvarez-Jiminez et al [77]
conducted a novel strengths and mindfulness-based online social
therapy for individuals at CHR-P. Participants found the
intervention acceptable and showed an improvement in social
functioning and subjective well-being, warranting further study.
Digital interventions showing promise in established psychosis,
relevant to CHR-P, include avatar therapy [78], online CBT
skills program for hallucinations [79], mobile phone apps
delivering therapeutic interventions [80-82], and online
peer-to-to peer support networks, reported to increase feelings
of social connectedness [83]. Indeed, Rice et al [84] have
developed an e-mental health service providing
clinician-delivered Web chat counseling, a moderated
peer-to-peer social network, and user directed online therapy.
This enhanced moderated online social therapy is seeded in
eheadspace, part of headspace, a flagship Australian youth
mental health program with an integrated early intervention in
psychosis component [85].
An important aspect of the clinical presentation of CHR-P is
cognitive deficits across a range of domains associated with
transition to psychosis [86,87]. One way of targeting cognitive
deficits in CHR participants could be cognitive remediation
(CR)–based treatments [88] that can be administered via
computerized training procedures [89]. These approaches
improve neural circuits underlying cognitive deficits with
significant impact on social functioning [90], especially if
administered in the early stages of schizophrenia [91]. There is
emerging evidence that CR treatments may be effective in
targeting cognitive dysfunctions in CHR participants. Loewy
et al [92] examined the effects of CR administered through
laptop and home computers on verbal learning and memory.
CR significantly improved verbal memory (effect size = 0.61)
as well as positive symptoms. Hooker et al [93] presented a
pilot uncontrolled study of cognitive training delivered online
for CHR-P, showing this intervention is feasible and appears
to provide improvements in the global cognition in response to
training.
Digital interventions could also be extended to address
functional impairments in CHR-P individuals. In a recent study,
Schlosser et al [82] examined a mobile-based digital health
intervention designed to improve motivation and quality of life
in young people with schizophrenia. Compared to the control
group, the active treatment arm demonstrated significant
improvements in levels of depression, defeatist beliefs, and
self-efficacy as well as a trend for improved negative symptoms.
These improvements were maintained 3 months after the end
of trial. Accordingly, these data suggest that mobile-based
interventions could be useful for addressing important domains
of functioning in CHR-P populations.
Virtual reality (VR) is an emerging tool for the treatment of a
wide range of mental disorders that involves interactive
computer-generated worlds in which therapeutic strategies can
be implemented and tested [94]. In established schizophrenia,
VR approaches have shown preliminary efficacy in targeting
positive symptoms, such as delusions [95] and hallucinations
[96], as well as increasing social participation [97]. VR has also
shown potential as a treatment adjunct in psychosis in modalities
such as cognitive remediation and social skills training [98],
showing preliminary promising results.
Following successful pilot research demonstrating the safety of
VR in the CHR-P population [99], this technique has been used
to investigate the effect of various simulated social environments
on psychopathology. A simulation of the London underground
transport system has been used to investigate paranoid ideation
[100,101] and perceived ethnic discrimination [102], while café
[103] and bar simulations [104] have been used to investigate
the effect of social stress on interpersonal distance and paranoid
ideation, respectively. These studies show the possibilities of
using VR to study psychopathology in a simulated environment.
Arguably, VR may be better suited as a treatment modality in
CHR-P compared with more established stages of psychosis.
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Table 1. Summary of included studies of e-mental health in clinical high risk for psychosis.
ResultsSummaryStudy and type
  E-Detection
Good to moderate sensitivity and specificity for predicting
CHR status based on online screening.
Web-based community screening for CHR-Pa.McDonald et al 2018 [47] 
Acceptable predictive performance; Harrell C of 0.80 (0.79-
0.82).
Risk calculator based on routine clinical data
of patients accessing secondary health services.
Fusar-Poli et al 2017 [18] 
Acceptable predictive performance; Harrell C of 0.73.External validation of the above study in a
second NHSb trust.
Fusar-Poli et al 2018 [51] 
N/A.Protocol for implementation study of the above
into routine clinical care.
Fusar-Poli et al 2019 [52] 
Acceptable predictive performance; Harrell C of 0.71.Risk calculator based on specialized clinical
assessment.
Cannon et al 2016 [53] 
Good discrimination area under the curve of 0.790 (0.644-
0.937).
External valiation of the above study in a sec-
ond cohort.
Carrión et al 2016 [54] 
  E-Prognosis
A total of 82% (36/42) of participants were compliant with
the smartphone measures.
Feasibility of smartphone self-report of symp-
toms using the ClinTouch app.
Palmier-Claus et al 2012 [59] 
Effects of stress on psychotic experiences were mediated
through affective disturbance.
ESMc study of stress and psychotic symptoms
using the PsyMate app.
Klippel et al 2017 [60] 
Outsider status and threat anticipation were associated with
more intensive psychotic experiences in those who experi-
ESM study of threat perception and psychotic
experiences using PsyMate app.
Reininghaus et al 2016 [61] 
enced sexual abuse compared with those exposed to low
levels of sexual abuse.
Elevated stress sensitivity, aberrant salience, and enhanced
threat anticipation were associated with increased intensity
of psychotic experiences.
ESM study of sensitivity to outsider status,
salient experiences, and psychotic experiences
using the PsyMate app.
Reininghaus et al 2016 [62] 
Greater associations between negative affect and stress
compared with psychotic patients (P=.008) and controls
(P<.001).
ESM study of affective and psychotic experi-
ences in response to stress using a digital wrist
watch to instruct participants to enter written
self-report at random time points.
van der Steen et al 2017 [63] 
  E-Treatment
Of the 70% actively engaged during the study, all reported
positive experiences, considered it safe, and would recom-
Pilot study of the online social therapy interven-
tion, Momentum.
Alvarez-Jimenez et al 2018 [77] 
mend it to others; 93% reported it to be helpful. Large im-
provements in social functioning (d=1.83, P<.001) and
subjective well-being (d=0.75, P=.03).
N/A.Study protocol for enhanced moderated online
social therapy (MOST).
Rice et al 2018 [84] 
Targeted cognitive training showed a significant improve-
ment in verbal memory compared to CG participants (effect
Randomized trial investigating the effective-
ness of auditory-processing exercises adminis-
Loewy et al 2019 [92] 
size = 0.61). Positive and total symptoms improved in both
groups over time.
tered through laptops in CHR-participants
compared to the effects of computer games
(CG) training.
Significant improvements in processing speed (P=.01,
d=0.63) and nonsignificant improvements in visual learning
Pilot uncontrolled study of online cognitive
training.
Hooker et al 2014 [93] 
and memory (P=.06, d=0.54) and global cognition (P=.06,
d=0.45).
No adverse events; no increase in mean anxiety score
(P=.29).
Study of the feasibility and safety of VRe envi-
ronments.
Valmaggia et al 2007 [99] 
More paranoid appraisals of VR simulations compared
with controls (P<.001).
VR study assessing childhood bullying and
paranoid ideation in a simulation of the London
underground.
Valmaggia et al 2015 [101] 
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ResultsSummaryStudy and type
More paranoid ideation during VR simulation compared
with controls χ2(1)=21.06, (P<.001).
VR study assessing social defeat and paranoid
appraisals in a simulation of the London under-
ground.
Valmaggia et al 2015 [100] 
Higher levels of perceived ethnic discrimination correlated
with greater paranoid persecutory ideation in VR environ-
ment r=0.25, P=.009.
VR study assessing ethnic discrimination and
persecutory paranoia in a simulation of the
London underground.
Shaikh et al 2016 [102] 
Interpersonal distance increased when social stressors were
present in the environment F=3.02, P=.02.
VR study assessing interpersonal distance
regulation in a simulated café.
Geraets et al 2018 [103] 
Increased paranoia compared with controls, regression co-
efficient 3.80 (95%CI 0.24–7.37) P=.04.
VR study assessing paranoia in a simulated bar
environment.
Veling et al 2016 [104] 
aCHR-P: clinical high risk of psychosis.
bNHS: National Health Service.
cESM: experience sampling method.
dVR: virtual reality.
Conclusion
Digital technologies are at present underused as a research or
clinical tool for CHR-P and may be ideally placed to address
the current challenges of the field. These include detecting those
at risk of psychosis outside specialized CHR-P clinics,
monitoring to predict future development of psychosis,
identifying digital biomarkers for psychosis and other clinical
outcomes, and delivering novel treatment modalities.
Furthermore, individuals at CHR-P, by definition young and
help-seeking, are ideally suited to digital interventions.
However, longitudinal studies of digital technologies are
required to assess which measures are useful for predicting risk
of psychosis in individuals identified by online screening. Future
research is required to rigorously test whether digital
interventions have a place in the detection or management in
people at CHR-P. In addition, we need greater understanding
of the relationship between the different types of measures (eg,
active and passive data collected via ESM and digital
phenotyping, respectively) in order to develop and validate
e-tools that provide maximal information while minimizing
burden on the patient.
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